TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies
✍ Scribed by Stefanie J Klug; Meike Ressing; Jochem Koenig; Martin C Abba; Theodoros Agorastos; Sylvia MF Brenna; Marco Ciotti; BR Das; Annarosa Del Mistro; Aleksandra Dybikowska; Anna R Giuliano; Zivile Gudleviciene; Ulf Gyllensten; Andrea LF Haws; Aslaug Helland; C Simon Herrington; Alan Hildesheim; Olivier Humbey; Sun H Jee; Jae Weon Kim; Margaret M Madeleine; Joseph Menczer; Hextan YS Ngan; Akira Nishikawa; Yoshimitsu Niwa; Rosemary Pegoraro; MR Pillai; Gulielmina Ranzani; Giovanni Rezza; Adam N Rosenthal; Susanta Roychoudhury; Dhananjaya Saranath; Virginia M Schmitt; Sharmila Sengupta; Wannapa Settheetham-Ishida; Hiroshi Shirasawa; Peter JF Snijders; Mark H Stoler; Angel E Suárez-Rincón; Krisztina Szarka; Ruth Tachezy; Masatsugu Ueda; Ate GJ van der Zee; Magnus von Knebel Doeberitz; Ming-Tsang Wu; Tsuyoshi Yamashita; Ingeborg Zehbe; Maria Blettner
- Book ID
- 117785076
- Publisher
- The Lancet
- Year
- 2009
- Tongue
- English
- Weight
- 231 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1470-2045
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Arg72Pro is a common polymorphism in __TP53,__ showing differences in its biological functions. Case‐control studies have been performed to elucidate the role of Arg72Pro in cancer, although the results are conflicting and heterogeneous. Here, we analyzed pooled data from case‐control s